Sarah Maenhout

1.3k total citations
13 papers, 889 citations indexed

About

Sarah Maenhout is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Sarah Maenhout has authored 13 papers receiving a total of 889 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 8 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Sarah Maenhout's work include Immunotherapy and Immune Responses (6 papers), Immune cells in cancer (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Sarah Maenhout is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Immune cells in cancer (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Sarah Maenhout collaborates with scholars based in Belgium, Luxembourg and Spain. Sarah Maenhout's co-authors include Kris Thielemans, Joeri L. Aerts, Karine Breckpot, Sandra Van Lint, Carlo Heirman, Stephanie Du Four, Sven de Mey, Wout de Mey, Hanne Locy and Mark De Ridder and has published in prestigious journals such as The Journal of Immunology, Cancer Research and International Journal of Cancer.

In The Last Decade

Sarah Maenhout

13 papers receiving 878 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah Maenhout Belgium	13	552	425	395	121	98	13	889
Jason M. Redman United States	16	583 1.1×	571 1.3×	284 0.7×	112 0.9×	58 0.6×	53	1.0k
Jan Martínek United States	7	492 0.9×	397 0.9×	244 0.6×	64 0.5×	117 1.2×	14	924
Xuexiang Du United States	10	504 0.9×	586 1.4×	204 0.5×	59 0.5×	96 1.0×	21	856
Axel Mischo Switzerland	17	284 0.5×	339 0.8×	427 1.1×	179 1.5×	96 1.0×	40	900
Jan L. Fisher United States	20	825 1.5×	703 1.7×	412 1.0×	96 0.8×	56 0.6×	37	1.3k
Iva Truxová Czechia	16	729 1.3×	648 1.5×	299 0.8×	104 0.9×	30 0.3×	24	1.2k
Nan Ring United States	7	782 1.4×	464 1.1×	258 0.7×	57 0.5×	58 0.6×	12	1.1k
Bangxing Hong United States	18	578 1.0×	445 1.0×	344 0.9×	45 0.4×	190 1.9×	37	1.0k
Qianqian Duan China	7	340 0.6×	378 0.9×	293 0.7×	169 1.4×	41 0.4×	31	792
Lupe G. Salazar United States	17	878 1.6×	787 1.9×	362 0.9×	88 0.7×	50 0.5×	42	1.2k

Countries citing papers authored by Sarah Maenhout

Since Specialization

Citations

This map shows the geographic impact of Sarah Maenhout's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Maenhout with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Maenhout more than expected).

Fields of papers citing papers by Sarah Maenhout

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Maenhout. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Maenhout. The network helps show where Sarah Maenhout may publish in the future.

Co-authorship network of co-authors of Sarah Maenhout

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Maenhout. A scholar is included among the top collaborators of Sarah Maenhout based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Maenhout. Sarah Maenhout is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Locy, Hanne, Sven de Mey, Wout de Mey, et al.. (2018). Immunomodulation of the Tumor Microenvironment: Turn Foe Into Friend. Frontiers in Immunology. 9. 2909–2909. 187 indexed citations

Lint, Sandra Van, Dries Renmans, Katrijn Broos, et al.. (2016). Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells. Cancer Immunology Research. 4(2). 146–156. 101 indexed citations

Four, Stephanie Du, Sarah Maenhout, Daphné Benteyn, et al.. (2016). Disease progression in recurrent glioblastoma patients treated with the VEGFR inhibitor axitinib is associated with increased regulatory T cell numbers and T cell exhaustion. Cancer Immunology Immunotherapy. 65(6). 727–740. 37 indexed citations

Four, Stephanie Du, Sarah Maenhout, Simone P. Niclou, et al.. (2016). Combined VEGFR and CTLA-4 blockade increases the antigen-presenting function of intratumoral DCs and reduces the suppressive capacity of intratumoral MDSCs.. PubMed. 6(11). 2514–2531. 64 indexed citations

Four, Stephanie Du, Sarah Maenhout, Dries Renmans, et al.. (2015). Axitinib increases the infiltration of immune cells and reduces the suppressive capacity of monocytic MDSCs in an intracranial mouse melanoma model. OncoImmunology. 4(4). e998107–e998107. 63 indexed citations

Maenhout, Sarah, Kris Thielemans, & Joeri L. Aerts. (2014). Location, location, location: functional and phenotypic heterogeneity between tumor-infiltrating and non-infiltrating myeloid-derived suppressor cells. OncoImmunology. 3(10). e956579–e956579. 65 indexed citations

Maenhout, Sarah, Stephanie Du Four, Jurgen Corthals, et al.. (2014). AZD1480 delays tumor growth in a melanoma model while enhancing the suppressive activity of myeloid-derived suppressor cells. Oncotarget. 5(16). 6801–6815. 14 indexed citations

Maenhout, Sarah, Sandra Van Lint, Perpetua U. Emeagi, Kris Thielemans, & Joeri L. Aerts. (2013). Enhanced suppressive capacity of tumor‐infiltrating myeloid‐derived suppressor cells compared with their peripheral counterparts. International Journal of Cancer. 134(5). 1077–1090. 55 indexed citations

Emeagi, Perpetua U., Sarah Maenhout, Nam H. Dang, et al.. (2013). Downregulation of Stat3 in melanoma: reprogramming the immune microenvironment as an anticancer therapeutic strategy. Gene Therapy. 20(11). 1085–1092. 34 indexed citations

10.

Emeagi, Perpetua U., Cleo Goyvaerts, Sarah Maenhout, et al.. (2013). Lentiviral Vectors: A Versatile Tool to Fight Cancer. Current Molecular Medicine. 13(4). 602–625. 25 indexed citations

11.

Pen, Joeri J., Brenda De Keersmaecker, Sarah Maenhout, et al.. (2013). Modulation of Regulatory T Cell Function by Monocyte-Derived Dendritic Cells Matured through Electroporation with mRNA Encoding CD40 Ligand, Constitutively Active TLR4, and CD70. The Journal of Immunology. 191(4). 1976–1983. 46 indexed citations

12.

Emeagi, Perpetua U., Sandra Van Lint, Cleo Goyvaerts, et al.. (2012). Proinflammatory Characteristics of SMAC/DIABLO-Induced Cell Death in Antitumor Therapy. Cancer Research. 72(6). 1342–1352. 26 indexed citations

13.

Lint, Sandra Van, Cleo Goyvaerts, Sarah Maenhout, et al.. (2012). Preclinical Evaluation of TriMix and Antigen mRNA-Based Antitumor Therapy. Cancer Research. 72(7). 1661–1671. 172 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact